MedImmune

MedImmune is a biotechnology company that focuses on developing innovative medicines, primarily vaccines and therapies for serious diseases like cancer, respiratory illnesses, and infections. They utilize advanced science to create targeted treatments that can improve patient health. MedImmune was acquired by AstraZeneca in 2007 and now operates as its immunology research arm, working on cutting-edge biologic medicines to address unmet medical needs. Their work involves developing drugs that help the body's immune system fight diseases more effectively.